List of Tables
Table 1. Global Ophthalmic AAV Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Subretinal Injection
Table 3. Key Players of Intravitreous Injection
Table 4. Global Ophthalmic AAV Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Ophthalmic AAV Gene Therapy Market Share by Region (2021–2026)
Table 8. Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Ophthalmic AAV Gene Therapy Market Share by Region (2027–2032)
Table 10. Ophthalmic AAV Gene Therapy Market Trends
Table 11. Ophthalmic AAV Gene Therapy Market Drivers
Table 12. Ophthalmic AAV Gene Therapy Market Challenges
Table 13. Ophthalmic AAV Gene Therapy Market Restraints
Table 14. Global Ophthalmic AAV Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Ophthalmic AAV Gene Therapy Market Share by Players (2021–2026)
Table 16. Global Top Ophthalmic AAV Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ophthalmic AAV Gene Therapy Revenue, 2025
Table 17. Ranking of Global Top Ophthalmic AAV Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Ophthalmic AAV Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Ophthalmic AAV Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Ophthalmic AAV Gene Therapy, Products and Applications
Table 21. Global Key Players of Ophthalmic AAV Gene Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Ophthalmic AAV Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Ophthalmic AAV Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Spark/Roche (Luxturna) Company Details
Table 47. Spark/Roche (Luxturna) Business Overview
Table 48. Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Product
Table 49. Spark/Roche (Luxturna) Revenue in Ophthalmic AAV Gene Therapy Business (US$ Million), 2021–2026
Table 50. Spark/Roche (Luxturna) Recent Development
Table 51. GenSight Biologics (Pipeline) Company Details
Table 52. GenSight Biologics (Pipeline) Business Overview
Table 53. GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Product
Table 54. GenSight Biologics (Pipeline) Revenue in Ophthalmic AAV Gene Therapy Business (US$ Million), 2021–2026
Table 55. GenSight Biologics (Pipeline) Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
Table 59. Authors List of This Report
List of Figures
Figure 1. Ophthalmic AAV Gene Therapy Picture
Figure 2. Global Ophthalmic AAV Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Ophthalmic AAV Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. Subretinal Injection Features
Figure 5. Intravitreous Injection Features
Figure 6. Global Ophthalmic AAV Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Ophthalmic AAV Gene Therapy Market Share by Application: 2025 vs 2032
Figure 8. Retinopathy Case Studies
Figure 9. Optic Atrophy Case Studies
Figure 10. Ophthalmic AAV Gene Therapy Report Years Considered
Figure 11. Global Ophthalmic AAV Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Ophthalmic AAV Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Ophthalmic AAV Gene Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Ophthalmic AAV Gene Therapy Market Share by Players in 2025
Figure 15. Global Ophthalmic AAV Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Ophthalmic AAV Gene Therapy Revenue in 2025
Figure 17. North America Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 19. United States Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 23. Germany Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Ophthalmic AAV Gene Therapy Market Share by Region (2021–2032)
Figure 31. China Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 43. Israel Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Spark/Roche (Luxturna) Revenue Growth Rate in Ophthalmic AAV Gene Therapy Business (2021–2026)
Figure 47. GenSight Biologics (Pipeline) Revenue Growth Rate in Ophthalmic AAV Gene Therapy Business (2021–2026)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
